Detalles de la búsqueda
1.
Effect of Ixekizumab on Patient Reported Outcomes and Quality of Life in Patients With Moderate-to-Severe Plaque Psoriasis: 5-Year Results from the UNCOVER-1 and -2 Studies.
J Drugs Dermatol
; 20(4): 394-401, 2021 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33852247
2.
A randomized, double-blind phase 4 study of the efficacy and safety of ethanol-free clobetasol propionate foam, 0.05%, vs vehicle foam in the treatment of chronic hand dermatitis.
J Drugs Dermatol
; 12(3): 328-34, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23545917
3.
A multicenter, randomized, double-blind study of the efficacy and safety of calcipotriene foam, 0.005%, vs vehicle foam in the treatment of plaque-type psoriasis of the scalp.
J Drugs Dermatol
; 12(3): 300-6, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23545912
4.
Mirikizumab Improves Quality of Life in Patients With Moderately-to-Severely Active Ulcerative Colitis: Results From the Phase 3 LUCENT-1 Induction and LUCENT-2 Maintenance Studies.
Crohns Colitis 360
; 5(4): otad070, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-38034882
5.
Real-World Biologic Adherence, Persistence, and Monotherapy Comparisons in US Patients with Psoriasis: Results from IBM MarketScan® Databases.
Adv Ther
; 39(7): 3214-3224, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35570242
6.
Clinical response beyond the Systemic Lupus Erythematosus Responder Index: post-hoc analysis of the BLISS-SC study.
Lupus Sci Med
; 5(1): e000288, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30588323
7.
Assessing attributes of topical vehicles for the treatment of acne, atopic dermatitis, and plaque psoriasis.
Cutis
; 94(1): 46-53, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25101344
Resultados
1 -
7
de 7
1
Próxima >
>>